60
Participants
Start Date
July 10, 2025
Primary Completion Date
July 31, 2028
Study Completion Date
July 31, 2035
ACT001
PO BID at 875 mg/m2 for 28 days
NOT_YET_RECRUITING
Sydney Children's Hospital, Randwick
NOT_YET_RECRUITING
Royal Children's Hospital, Melbourne
NOT_YET_RECRUITING
Queensland Children's Hospital, South Brisbane
NOT_YET_RECRUITING
Perth Children's Hospital, Perth
NOT_YET_RECRUITING
Children's Hospital of Philidelphia, Philidelphia
NOT_YET_RECRUITING
Children's National Medical Center, Washington D.C.
NOT_YET_RECRUITING
Duke University Medical Center, Durham
NOT_YET_RECRUITING
Emory University/Children's Healthcare of Atlanta, Atlanta
NOT_YET_RECRUITING
Nicklaus Children's Hospital, Miami
RECRUITING
Nationwide Children's Hospital, Columbus
NOT_YET_RECRUITING
Cincinnati Children's Hospital, Cincinnati
NOT_YET_RECRUITING
C.S. Mott Children's Hospital, Ann Arbor
NOT_YET_RECRUITING
St. Louis Children's Hospital, St Louis
NOT_YET_RECRUITING
Hopp Children's Cancer Center at NCT Heidelberg (KiTZ), Heidelberg
NOT_YET_RECRUITING
Texas Children's Hospital, Houston
NOT_YET_RECRUITING
Seattle Children's Hospital, Seattle
NOT_YET_RECRUITING
The Hospital for Sick Children (SickKids), Toronto
NOT_YET_RECRUITING
Montreal Children's Hospital, Montreal
Collaborators (1)
Accendatech USA Inc.
INDUSTRY
Nationwide Children's Hospital
OTHER